FTSE 100 Rises on Optimism Over Potential Fed Rate Cuts

London's FTSE 100 hit a one-week high, buoyed by investor optimism over potential interest rate cuts by the Federal Reserve following a drop in U.S. inflation. Pharmaceutical and biotech stocks led the gains, while precious metal miners faced declines. The market focus now shifts to U.S. producer price data and upcoming UK consumer prices figures.

London's FTSE 100 index reached a one-week high on Friday, bolstered by growing investor hopes for a September interest rate cut by the Federal Reserve. This optimism followed a surprising decline in U.S. inflation data.

The blue-chip FTSE 100 index climbed by 0.4%, whereas the mid-cap FTSE 250 marginally fell by 0.1% at 0717 GMT, despite hitting a more than two-year high on Thursday. Both indexes are set to record their second consecutive weekly gains.

Global investor sentiment improved with increased expectations of a Fed rate cut in September after U.S. consumer prices unexpectedly dropped in June. London's pharmaceutical and biotech stocks advanced by 1.4%, while medical equipment and services shares rose 0.7%, continuing their rallies.

Heavy-weight banks saw a 0.7% increase, and energy shares rose by 0.4% on the back of higher oil prices, though they are likely to underperform their peers this week. Precious metal miners dropped by 0.6%, mirroring a decline in gold prices.

Attention is now on U.S. producer prices data, which could further validate the case for September rate cuts. As a new earnings season begins in major economies, investors will monitor quarterly results for insights into corporate health.

Next week’s UK consumer prices figures will be crucial, especially with the imminent Bank of England meeting and a new government in place. Ashmore fell 3.9% after reporting a $2 billion quarterly net outflow of client cash, reflecting investor hesitation towards its emerging markets funds.